LHC-165 is an agonist (activator) of Toll-like Receptor 7 (TLR7), and an immuno-oncology modulator. TLR7 is a protein in the immune system that surveys and recognizes pathological malignance, and triggers the immune response by releasing infection-clearing cytokines if activated. It has demonstrated in mice that LHC-165 induced immune response, and reduced tumor growth, also showed signs of an abscopal effect.

KEYWORDS: LHC-165 | Supplier | Toll-like Receptor 7 agonist | LHC165 | LHC 165 | CT-LHC165 | CAS [1258595-14-0] | DNA-RNA | TLR7 | Agonist | Receptors